Front Page

States’ Prescription Drug Transparency Laws Open the Black Box of Drug Pricing

Several states have passed drug price transparency laws that require drug makers to report the reasons behind dramatic price increases. These laws are an important first step to shine a light on why drug prices are rapidly climbing. To address a problem, state health policymakers need to understand it, but transparency laws don’t yet give […]

Read More
  • Leveraging State Purchasing Power to Stabilize the Individual Insurance Market: Washington State Leads the Way
    State Health Policy Blog

    Washington state has enacted a groundbreaking law to help stabilize its individual insurance market and prevent “bare counties,” areas of the state without an insurance option on its exchange. Sponsored by longtime National Academy for State Health Policy (NASHP) member, state Rep. Eileen Cody, HB 2408 requires insurance plans covering state or school employees to offer at least […]

    Read More
  • The Evolving Promise of Delivery System Reform Incentive Programs
    State Health Policy Blog

    Among the transformation initiatives states are undertaking to revamp, strengthen, and sustain their Medicaid delivery systems are provider payment incentives designed to lower costs and improve quality of care and health outcomes. A recent National Academy for State Health Policy (NASHP) report on Delivery System Reform Incentive Payment (DSRIP) programs and similar state incentive programs, […]

    Read More
  • Mental Health and Opioid Crisis Programs Win Funding Hikes, Efforts to Stabilize Insurance Markets Fail
    State Health Policy Blog

    The new $1.3 trillion budget bill that finances the federal government through September increased funding for a number of health programs that directly impact states, including rural programs to combat the opioid crisis. There were no appropriations made to stabilize Affordable Care Act (ACA) insurance markets. Under the budget, the Department of Health and Human […]

    Read More
    March 27, 2018 | Filed under: ACA, Blog Posts, Front Page, State Health Policy Blog
  • NASHP State Leaders Meet to Reflect and Plan in a Changing Health Care Environment
    State Health Policy Blog

    Last week, 24 National Academy for State Health Policy (NASHP) leaders, including state lawmakers and representatives from governors’, budget, and insurance offices, Medicaid and public health agencies, and insurance exchanges, CHIP and health policy commissions met in Washington, DC, to assess the issues and opportunities confronting state health policymakers. The robust discussion helps NASHP set […]

    Read More
    March 27, 2018 | Filed under: Blog Posts, Front Page, State Health Policy Blog
  • State and Federal Officials Explore Ways to Promote Healthy Child Development in a New Era
    Publications

    The first years of life significantly impact long-term health and well-being and policymakers have worked hard to create initiatives that help children during this important period. Recently, the National Academy for State Health Policy (NASHP) convened state and federal leaders from agencies serving young children to discuss innovative approaches to advance healthy child development in […]

    Read More
  • Legal Challenges of Rx Drug Laws Passed in 2017 Will Shape States’ Future Cost Containment Legislation
    Publications

    As the number of state bills to rein in prescription drug prices grows beyond 150 nationwide in 2018, the first generation of several state laws passed last year are now before the courts. The pharmaceutical industry has consistently challenged drug cost transparency and price gouging legislation passed in 2017 in federal courts. How well these […]

    Read More
  • How Elimination of Cost-Sharing Reduction Payments Changed Consumer Enrollment in State-Based Marketplaces
    State Health Policy Blog

    State health policymakers are eagerly waiting to see if Congress’ omnibus budget bill released this week will attempt to stabilize Affordable Care Act (ACA) insurance markets by reinstating ACA’s cost-sharing reduction (CSR) payments. An early proposal by US Sen. Lamar Alexander would fund the cost-sharing subsidies, which reduce a family’s out-of-pocket health care costs, retroactively […]

    Read More
    March 20, 2018 | Filed under: Blog Posts, Front Page, State Health Policy Blog
  • An Oregon State Lawmaker Crafts a Winning Strategy for Transparency Legislation

    Last week, Oregon Gov. Kate Brown signed a drug cost transparency bill into law that requires drug makers to report the reasons behind dramatic drug price increases. The bill’s leading advocate and architect, state Rep. Robert Nosse, D-Portland, worked for nearly three years to create a prescription cost containment bill that would win bipartisan support […]

    Read More
  • Can States Regulate Drug Costs without Violating Patent Law? Yes, Here’s Why
    State Health Policy Blog

    When states pass laws that enable them to regulate prescription drug costs or mandate drug pricing transparency, the pharmaceutical industry always fires back with lawsuits claiming the states are violating federal law. In 2017, the industry sued every state that enacted drug cost containment legislation claiming they had violated myriad federal laws, including the Patent […]

    Read More